Novo Nordisk’s raised forecast fails to change the debate over its obesity business

Novo Nordisk’s quarterly beat and guidance increase did little to resolve Wall Street’s biggest concern: whether the Ozempic maker has a convincing path back to sustainable growth as competition from Eli Lilly intensifies. Analysts said the better-than-expected quarter benefited from rebate adjustments and other temporary factors, obesity drug sales were broadly in line with expectations,…

Read More

Asian tech rally, SK Hynix, Samsung, Advantest

CANADA – 2025/08/07: In this photo illustration, the SoftBank Group (Soft Bank) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) Sopa Images | Lightrocket | Getty Images Asian technology stocks surged Wednesday after a strong Wall Street rally overnight that saw robust corporate earnings and easing…

Read More